What happens during a telehealth GLP-1 consultation
The Noom program has comprehensive data on patient health, injection dates, side effects, and weight-loss speed, and we bring that data to bear to personalize the dosing to maximize outcomes and adherence not just to the medication, but to our Noom microhabits program. While many eligible GLP-1 users are deterred from starting medication due to fear of incurring side effects, others are challenged by high medication costs
Understanding your genetic predispositions in GLP-1 and metabolic pathways can support a more personalized discussion with your provider about maintenance dose selection, adjustment thresholds, and biomarker targets
Expert care and administration by Dr
Third, oral semaglutide (Wegovy pill, $149/mo at Walgreens) entered US distribution in late 2025, giving needle-averse patients a brand-name option for the first time